Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05615389 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilot Study of MC in Paediatric Palliative Care

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Oct 2025 to Oct 2026 Completion date: Dec 2025 to Dec 2026v8 Show 1 more changeShow less
    • Completion date: Dec 2025 to Dec 2026
  2. Primary completion date: Dec 2024 to Oct 2025 Completion date: Feb 2025 to Dec 2025v7 Show 1 more changeShow less
    • Completion date: Feb 2025 to Dec 2025
  3. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Feb 2024 to Dec 2024 · Completion date: Jun 2024 to Feb 2025 · Start date changed from estimate of Dec 2023 to Feb 19, 2024 · 1 morev6 Show 4 more changesShow less
    • Primary completion date: Feb 2024 to Dec 2024
    • Completion date: Jun 2024 to Feb 2025
    • Start date changed from estimate of Dec 2023 to Feb 19, 2024
    • Site details revised
  4. Start date: Sep 2023 to Dec 2023v5
  5. Start date: Jun 26, 2023 to Sep 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Mar 31, 2023 to Jun 26, 2023v3
  2. Start date: Dec 2022 to Mar 31, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this pilot study is to explore the feasibility and acceptability of a medicinal cannabis clinical trial into easing the symptoms of children undergoing palliative care for non-oncological conditions. The trial will evaluate the study design including recruitment strategy, medication tolerability, duration and outcomes to determine acceptability and feasibility for participating families. The data collected will then be used to design a full-scale multi-centre trial. Participants will be randomly allocated to receive one of two medicinal cannabis products. Neither the participants nor researchers will know the study drug allocation until the end of the trial.
Trial Details
NCT Number NCT05615389
Lead Sponsor Murdoch Childrens Research Institute
Conditions Palliative Care
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov